This content is from: Premium
EcoR1 Targets Biotech Company
The hedge fund founded by 2015 Hedge Fund Rising Star Oleg Nodelman bought nearly 9 million shares in a developmental company in one day.
A little known but successful hedge fund that specializes in biotech companies has taken a huge and possibly activist stake in a clinical-stage biotechnology company whose stock is badly beaten down.On August 23, Oleg Nodelman’s EcoR1 Capital bought a little more than 8.7 million shares of Prothena Corporation in the
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.